What You Need to Know Ahead of Stryker's Earnings Release

Portage, Michigan-based Stryker Corporation (SYK) operates as a medical technology company that develops, manufactures, and markets specialty surgical and medical products. Valued at $141.2 billion by market cap, the company's products include implants, surgical, neurologic, ear, nose and throat and interventional pain equipment, endoscopic, surgical navigation, digital imaging systems, as well as patient handling and emergency medical equipment. The Medtech giant is expected to announce its fiscal third-quarter earnings for 2025 after the market closes on Thursday, Oct. 30.

Ahead of the event, analysts expect SYK to report a profit of $3.14 per share on a diluted basis, up 9.4% from $2.87 per share in the year-ago quarter. The company has consistently surpassed Wall Street’s EPS estimates in its last four quarterly reports.